Hims to Sell Lilly’s Zepbound Through Telehealth Platform

Hims & Hers Health Inc.’s shares rose Tuesday after it said it was broadening its weight-loss offerings, adding access to brand name shots like Zepbound after previously focusing on cheaper versions made by compounding pharmacies.

Hims shares gained 5.1% in New York on Tuesday.